Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof
Details for Australian Patent Application No. 2002300880 (hide)
International Classifications
Event Publications
20 February 2003 Application Open to Public Inspection
Published as AU-B-2002300880
18 September 2003 Amendment Made
The nature of the amendment is: Amend the name of the applicant/patentee from The Ludwig Institute for Cancer Research and Helsinki University Licensing Ltd. Oy to The Ludwig Institute for Cancer Research and Licentia, Ltd.
9 March 2006 Application Accepted
Published as AU-B-2002300880
6 July 2006 Standard Patent Sealed
13 July 2006 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 10 Feb 2006. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
30 November 2006 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 10 Feb 2006
11 December 2008 Assignment Registered
Licentia, Ltd.; The Ludwig Institute for Cancer Research The patent has been assigned to Vegenics Limited
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser